SIM
PRME icon

Sandia Investment Management’s Prime Medicine PRME Stock Holding History

Sandia Investment Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,084
Closed -$9.6K – 160
2023
Q4 		$9.6K Sell
1,084
-8,916
-89% -$68.7K 0.01% 150
2023
Q3 		$95.4K Hold
10,000
– – 0.03% 153
2023
Q2 		$147K Hold
10,000
– – 0.03% 139
2023
Q1 		$123K Hold
10,000
– – 0.02% 159
2022
Q4 		$186K Buy
+10,000
New +$181K 0.03% 142

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sandia Investment Management's PRME Position: Q1 2024 in Review

Sandia Investment Management sold out of Prime Medicine (PRME) in Q1 2024, closing a stake of 1,084 shares — an estimated $9.6K sold.

Sandia Investment Management first reported a position in PRME in Q4 2022 and held it in 5 quarters. The position peaked at $186K in Q4 2022. 115 funds tracked by Wall St. Rank hold PRME as of Q1 2024.

  • Sandia Investment Management reported no remaining Prime Medicine position as of Q1 2024 after selling out during the quarter.
  • Sandia Investment Management sold 1,084 Prime Medicine shares in Q1 2024, an estimated $9.6K.
  • Sandia Investment Management first reported a position in Prime Medicine in Q4 2022 and held it in 5 quarters.
  • Sandia Investment Management's Prime Medicine position peaked at $186K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2024.

Based on Sandia Investment Management's 13F filing for Q1 2024, filed 15 May 2024.